Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection

Dig Liver Dis. 2022 Nov;54(11):1598-1599. doi: 10.1016/j.dld.2022.08.038. Epub 2022 Sep 6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Colitis, Ulcerative* / complications
  • Colitis, Ulcerative* / drug therapy
  • Humans
  • Pyrimidines / therapeutic use
  • SARS-CoV-2

Substances

  • tofacitinib
  • Pyrimidines